213 related articles for article (PubMed ID: 23238591)
1. Phase II prospective open-label trial of recombinant interleukin-11 in desmopressin-unresponsive von Willebrand disease and mild or moderate haemophilia A.
Ragni MV; Novelli EM; Murshed A; Merricks EP; Kloos MT; Nichols TC
Thromb Haemost; 2013 Feb; 109(2):248-54. PubMed ID: 23238591
[TBL] [Abstract][Full Text] [Related]
2. A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand disease.
Ragni MV; Jankowitz RC; Chapman HL; Merricks EP; Kloos MT; Dillow AM; Nichols TC
Haemophilia; 2008 Sep; 14(5):968-77. PubMed ID: 18680527
[TBL] [Abstract][Full Text] [Related]
3. Comparative response of plasma VWF in dogs to up-regulation of VWF mRNA by interleukin-11 versus Weibel-Palade body release by desmopressin (DDAVP).
Olsen EH; McCain AS; Merricks EP; Fischer TH; Dillon IM; Raymer RA; Bellinger DA; Fahs SA; Montgomery RR; Keith JC; Schaub RG; Nichols TC
Blood; 2003 Jul; 102(2):436-41. PubMed ID: 12649145
[TBL] [Abstract][Full Text] [Related]
4. Phase II prospective open-label trial of recombinant interleukin-11 in women with mild von Willebrand disease and refractory menorrhagia.
Ragni MV; Jankowitz RC; Jaworski K; Merricks EP; Kloos MT; Nichols TC
Thromb Haemost; 2011 Oct; 106(4):641-5. PubMed ID: 21833452
[TBL] [Abstract][Full Text] [Related]
5. Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand disease.
Kavakli K; Hüseyinov A; Coker I; Aydinok Y; Nisli G
Haemophilia; 2001 Sep; 7(5):482-9. PubMed ID: 11554936
[TBL] [Abstract][Full Text] [Related]
6. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R
Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
[TBL] [Abstract][Full Text] [Related]
7. Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders.
Nolan B; White B; Smith J; O'Reily C; Fitzpatrick B; Smith OP
Br J Haematol; 2000 Jun; 109(4):865-9. PubMed ID: 10929043
[TBL] [Abstract][Full Text] [Related]
8. Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect.
Castaman G; Federici AB; Bernardi M; Moroni B; Bertoncello K; Rodeghiero F
J Thromb Haemost; 2006 Feb; 4(2):357-60. PubMed ID: 16420565
[TBL] [Abstract][Full Text] [Related]
9. Response of patients with hemophilia A and von Willebrand disease to desmopressin (DDAVP).
Santiago-Borrero PJ; Casanova R
Bol Asoc Med P R; 1990 May; 82(5):207-10. PubMed ID: 2115785
[TBL] [Abstract][Full Text] [Related]
10. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
11. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
12. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
[TBL] [Abstract][Full Text] [Related]
13. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease.
Mannucci PM; Canciani MT; Rota L; Donovan BS
Br J Haematol; 1981 Feb; 47(2):283-93. PubMed ID: 6781527
[TBL] [Abstract][Full Text] [Related]
14. Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP).
Mannucci PM; Bettega D; Cattaneo M
Br J Haematol; 1992 Sep; 82(1):87-93. PubMed ID: 1419807
[TBL] [Abstract][Full Text] [Related]
15. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
Michiels JJ; van Vliet HH
Acta Haematol; 2009; 121(2-3):154-66. PubMed ID: 19506362
[TBL] [Abstract][Full Text] [Related]
16. Assessment and validation of a defined fluid restriction protocol in the use of subcutaneous desmopressin for children with inherited bleeding disorders.
Mason JA; Robertson JD; McCosker J; Williams BA; Brown SA
Haemophilia; 2016 Sep; 22(5):700-5. PubMed ID: 27385253
[TBL] [Abstract][Full Text] [Related]
17. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease.
Gill JC; Ottum M; Schwartz B
J Pediatr; 2002 May; 140(5):595-9. PubMed ID: 12032528
[TBL] [Abstract][Full Text] [Related]
19. Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process?
Brown SA; Eldridge A; Collins PW; Bowen DJ
J Thromb Haemost; 2003 Aug; 1(8):1714-7. PubMed ID: 12911582
[TBL] [Abstract][Full Text] [Related]
20. Factor VIII:C increases after desmopressin in a subgroup of patients with autosomal recessive severe von Willebrand disease.
Castaman G; Lattuada A; Mannucci PM; Rodeghiero F
Br J Haematol; 1995 Jan; 89(1):147-51. PubMed ID: 7833254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
